The association – named the Applied Drug Delivery Institute – will provide training programmes, help establish partnerships between universities and business, and will work with regulatory bodies in an effort to solve industry-wide issues.
In a statement, senior VP of research and development (R&D) Kurt Nielsen said: “The mission of the Catalent Applied Drug Delivery Institute is to bring better treatments to market by advancing the development and adoption of applied drug delivery technologies.
Rao Tatapudy, VP of scientific affairs added: “We look forward to a continuous series of successful collaborations as the institute’s activities unfold.”
The firm launched the new organisation during a press conference at AAPS, where we spoke to the programme leaders about the reasons behind the move, the current happenings and what’s to come.
Read the article on next week’s Outsourcing-Pharma.com